Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.

@article{Yeh2016IntratrachealAO,
  title={Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.},
  author={Tsu Fu Yeh and Chung M Chen and Shou Y. Wu and Zahid Husan and Tsai Chung Li and Wu S Hsieh and Chang Hai Tsai and Hung Chou Lin},
  journal={American journal of respiratory and critical care medicine},
  year={2016},
  volume={193 1},
  pages={
          86-95
        }
}
RATIONALE Bronchopulmonary dysplasia (BPD) is an important complication of mechanical ventilation in preterm infants, and no definite therapy can eliminate this complication. [...] Key MethodMETHODS A clinical trial was conducted in three tertiary neonatal centers in the United States and Taiwan, in which 265 very-low-birth-weight infants with severe respiratory distress syndrome who required mechanical ventilation and inspired oxygen (fraction of inspired oxygen, ≥50%) within 4 hours of birth were randomly…Expand Abstract

Citations

Publications citing this paper.
SHOWING 1-10 OF 51 CITATIONS, ESTIMATED 45% COVERAGE

Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates

VIEW 14 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Bronchopulmonary dysplasia

FILTER CITATIONS BY YEAR

2016
2020

CITATION STATISTICS

  • 7 Highly Influenced Citations

  • Averaged 13 Citations per year from 2017 through 2019

References

Publications referenced by this paper.